Jazz Pharma Consensus Deemed Low and 4 Stock Analyses Making Rounds

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): Current Price: $56.57

According to Lazard Capital, consensus expectations for Jazz Pharmaceuticals have been too low after the company’s Xyrem price increase last week. The firm reiterates its Buy rating and an $87 price target on the stock.

Investors are making great returns as markets roar higher. Join the party. Click here to discover our Feature Stock Pick now!


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business